Georgia Institute of TechnologySchool of Chemical & Biomolecular Engineering

Mark R. Prausnitz

Mark R. Prausnitz

Regents' Professor, Love Family Professor in Chemical & Biomolecular Engineering, and Director of the Center for Drug Design, Development and Delivery

Contact Information

Building: Petit IBB
Office: 1312
Phone: 404.894.5135
Fax: 404.894.2291
email

Mailing Address

Georgia Institute of Technology
School of Chemical &
Biomolecular Engineering
311 Ferst Drive, N.W.
Atlanta, GA 30332-0100

Links

Laboratory for Drug Delivery

Publications

Patents

Mark R. Prausnitz


Education

B.S. 1988, Stanford University
Ph.D. 1994, Massachusetts Institute of Technology


Research Interests

Dr. Prausnitz and his colleagues carry out research on biophysical methods of drug delivery, which employ microneedles, ultrasound, lasers, electric fields, heat, convective forces and other physical means to control the transport of drugs, proteins, genes and vaccines into and within the body.

A major area of focus involves the use of microneedle patches to apply vaccines to the skin in a painless, minimally invasive manner. In collaboration with Emory University, the Centers for Disease Control and Prevention and other organizations, Dr. Prausnitz’s group is advancing microneedles from device design and fabrication through pharmaceutical formulation and pre-clinical animal studies through studies in human subjects. In addition to developing a self-administered influenza vaccine using microneedles, Dr. Prausnitz is translating microneedles technology especially to make vaccination in developing countries more effective.

The Prausnitz group has also developed hollow microneedles for injection into the skin and into the eye in collaboration with Emory University. In the skin, research focuses on insulin administration to human diabetic patients to increase onset of action by targeting insulin delivery to the skin. In the eye, hollow microneedles enable precise targeting of injection to the suprachoroidal space and other intraocular tissues for minimally invasive delivery to treat macular degeneration and other retinal diseases.

Dr. Prausnitz and colleagues also study novel mechanisms to deliver proteins, DNA and other molecules into cells. Cavitation bubble activity generated by ultrasound and by laser-excitation of carbon nanoparticles breaks open a small section of the cell membrane and thereby enables entry of molecules, which is useful for gene-based therapies and targeted drug delivery.

In addition to research activities, Dr. Prausnitz teaches an introductory course on engineering calculations, as well as two advanced courses on pharmaceuticals and technical communication, both of which he developed. He also serves the broader scientific and business communities as a frequent consultant, advisory board member and expert witness.